High-risk & critical care obstetrics / / senior editor, Nan H. Troiano ; editors, Patricia M. Witcher, Suzanne McMurtry Baird
| High-risk & critical care obstetrics / / senior editor, Nan H. Troiano ; editors, Patricia M. Witcher, Suzanne McMurtry Baird |
| Edizione | [Fourth edition.] |
| Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2019] |
| Descrizione fisica | 1 online resource (xvii, 426 pages) : illustrations |
| Disciplina | 618.2/0231 |
| Altri autori (Persone) |
TroianoNan H
WitcherPatricia M BairdSuzanne McMurtry |
| Soggetto topico |
Obstetric Nursing - methods
Critical Care Nursing - methods Delivery, Obstetric - nursing Obstetric Labor Complications - nursing Pregnancy Complications - nursing Pregnancy, High-Risk Maternity nursing Pregnancy - Complications - Nursing Labor (Obstetrics) - Complications - Nursing |
| ISBN |
1-9751-0849-3
1-4963-7999-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Maternal morbidity and mortality / Patricia M. Witcher and Michael Lindsey -- Improving maternal outcomes / Patricia M. Witcher, Cynthia Chazott, and Bonnie Flood Chez -- Critical care obstetric capabilities : development strategies / Suzanne McMurtry Baird and Stephanie Martin -- Invasive hemodynamic and oxygen transport monitoring during pregnancy / Nan H. Troiano And Sreedhar Gaddipati -- Mechanical ventilation during pregnancy / Nan H. Troiano and Thomas M. Jenkins -- Pharmacologic agents / Suzanne McMurtry Baird, Stephen D. Krau, and Michael A. Belfort -- Hypertension in pregnancy / Carol J. Harvey and Baha M. Sibai -- Cardiac disorders in pregnancy / Sreedhar Gaddipati and Nan H. Troiano -- Pulmonary disorders in pregnancy / Brian A. Mason and Karen Dorman -- Diabetic ketoacidosis and continuous insulin infusion management in pregnancy / Maribeth Inturrisi, Nancy C. Lintner, and Kimberlee Sorem -- Anesthesia emergencies in the obstetric setting / Patricia M. Witcher and Keith Mclendon -- Induction of labor / Washington C. Hill and Carol J. Harvey -- Acute renal failure /Betsy B. Kennedy, Carol J. Harvey, and George R. Saade -- Cardiopulmonary resuscitation in pregnancy / Deborah Anne Cruz, Patricia Marie Constanty, and Shailen S. Shah -- Obstetric hemorrhage / Carol J. Harvey and Gary A. Dildy -- Disseminated intravascular coagulation in pregnancy / Melissa C. Sisson and Marcy M. Mann -- Venous thromboembolism in pregnancy / Patricia M. Witcher and Lewis Hamner -- Sepsis in pregnancy / Julie M. R. Arafeh and Bonnie K. Dwyer -- Amniotic fluid embolus (anaphylactoid syndrome of pregnancy) / Renee' Jones and Steven L. Clark -- Perinatal infection / Patrick Duff -- Trauma in pregnancy / Donna Ruth and Richard S. Miller -- Maternal obesity : effects on pregnancy / Amy H. Picklesimer and Karen Dorman. |
| Altri titoli varianti | High-risk and critical care obstetrics |
| Record Nr. | UNINA-9910793380203321 |
| Philadelphia : , : Wolters Kluwer, , [2019] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
High-risk & critical care obstetrics / / senior editor, Nan H. Troiano ; editors, Patricia M. Witcher, Suzanne McMurtry Baird
| High-risk & critical care obstetrics / / senior editor, Nan H. Troiano ; editors, Patricia M. Witcher, Suzanne McMurtry Baird |
| Edizione | [4th ed.] |
| Pubbl/distr/stampa | Philadelphia, : Wolters Kluwer, [2019] |
| Descrizione fisica | 1 online resource (xvii, 426 pages) : illustrations |
| Disciplina | 618.2/0231 |
| Altri autori (Persone) |
TroianoNan H
WitcherPatricia M BairdSuzanne McMurtry |
| Soggetto topico |
Obstetric Nursing - methods
Critical Care Nursing - methods Delivery, Obstetric - nursing Obstetric Labor Complications - nursing Pregnancy Complications - nursing Pregnancy, High-Risk Maternity nursing Pregnancy - Complications - Nursing Labor (Obstetrics) - Complications - Nursing |
| ISBN |
9781975108496
1975108493 9781496379993 1496379993 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Maternal morbidity and mortality / Patricia M. Witcher and Michael Lindsey -- Improving maternal outcomes / Patricia M. Witcher, Cynthia Chazott, and Bonnie Flood Chez -- Critical care obstetric capabilities : development strategies / Suzanne McMurtry Baird and Stephanie Martin -- Invasive hemodynamic and oxygen transport monitoring during pregnancy / Nan H. Troiano And Sreedhar Gaddipati -- Mechanical ventilation during pregnancy / Nan H. Troiano and Thomas M. Jenkins -- Pharmacologic agents / Suzanne McMurtry Baird, Stephen D. Krau, and Michael A. Belfort -- Hypertension in pregnancy / Carol J. Harvey and Baha M. Sibai -- Cardiac disorders in pregnancy / Sreedhar Gaddipati and Nan H. Troiano -- Pulmonary disorders in pregnancy / Brian A. Mason and Karen Dorman -- Diabetic ketoacidosis and continuous insulin infusion management in pregnancy / Maribeth Inturrisi, Nancy C. Lintner, and Kimberlee Sorem -- Anesthesia emergencies in the obstetric setting / Patricia M. Witcher and Keith Mclendon -- Induction of labor / Washington C. Hill and Carol J. Harvey -- Acute renal failure /Betsy B. Kennedy, Carol J. Harvey, and George R. Saade -- Cardiopulmonary resuscitation in pregnancy / Deborah Anne Cruz, Patricia Marie Constanty, and Shailen S. Shah -- Obstetric hemorrhage / Carol J. Harvey and Gary A. Dildy -- Disseminated intravascular coagulation in pregnancy / Melissa C. Sisson and Marcy M. Mann -- Venous thromboembolism in pregnancy / Patricia M. Witcher and Lewis Hamner -- Sepsis in pregnancy / Julie M. R. Arafeh and Bonnie K. Dwyer -- Amniotic fluid embolus (anaphylactoid syndrome of pregnancy) / Renee' Jones and Steven L. Clark -- Perinatal infection / Patrick Duff -- Trauma in pregnancy / Donna Ruth and Richard S. Miller -- Maternal obesity : effects on pregnancy / Amy H. Picklesimer and Karen Dorman. |
| Altri titoli varianti | High-risk and critical care obstetrics |
| Record Nr. | UNINA-9910953761403321 |
| Philadelphia, : Wolters Kluwer, [2019] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong
| Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong |
| Edizione | [7th ed.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley-Blackwell, , 2024 |
| Descrizione fisica | 1 online resource (502 pages) |
| Disciplina | 618.3 |
| Soggetto topico |
Pregnancy Complications
Pregnancy, High-Risk Evidence-Based Medicine - methods |
| ISBN |
1-119-63654-X
1-119-63653-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Acknowledgments -- Part 1 Factors of High-Risk Pregnancy -- Chapter 1 Overview of High-Risk Pregnancy -- Chapter 2 Nutrition in Pregnancy -- Fetal growth -- Body mass index, weight gain, and adverse pregnancy outcomes -- Obesity -- Nutrition assessment and counseling -- Food security -- Energy intake during pregnancy -- Healthy dietary pattern in pregnancy -- Multivitamins -- Micronutrients in pregnancy -- Iron -- Folate/folic acid -- Calcium -- Vitamin D -- Iodine -- Vitamin toxicity -- Caffeine consumption in pregnancy -- Seafood consumption in pregnancy -- Multifetal pregnancy -- Nutrition during lactation -- Conclusion -- References -- Chapter 3 Alcohol and Substance Use Disorder -- Introduction -- Screening and testing for substance use disorder -- Alcohol -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Opioids -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Intrapartum and postpartum care -- Cannabis -- Stimulants -- Vaping (E-cigarettes) -- Benzodiazepines -- References -- Chapter 4 Environmental Agents and Reproductive Risk -- Background incidence of adverse outcome -- Biologic evidence of toxicity -- General principles -- Specific agents -- Lead -- Mercury -- Pesticides and herbicides -- Polychlorinated biphenyls -- Polybrominated diphenyl ethers -- Organic solvents -- Perfluorochemicals -- Video display terminals -- Bisphenol A -- Phthalates -- Air pollutants -- References -- Part 2 Genetics -- Chapter 5 Genetic Screening for Mendelian Disorders -- Family history -- Mendelian inheritance -- Carrier screening -- Carrier screening guidelines -- Hemoglobinopathies -- Cystic fibrosis -- Spinal muscular atrophy -- Fragile X syndrome -- Jewish genetic diseases -- Prenatal diagnosis -- Newborn screening.
References -- Chapter 6 Screening for Congenital Heart Disease -- Introduction -- Screening low-risk populations -- Benefits of cardiac screening -- High-risk populations for fetal echocardiography -- Normal fetal heart anatomy -- Technique -- Two-dimensional cross-sectional imaging -- Four-chamber view -- Ventricular outflow tracts -- Three-vessel and three-vessel trachea views -- Additional cardiac views -- Color Doppler imaging -- Expectations from cardiac screening -- Four-chamber view -- Addition of outflow tract views and three-vessel views -- Conclusion -- References -- Chapter 7 First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube Defects -- First-trimester sonographic screening -- Combined first-trimester serum and sonographic screening -- First-trimester cystic hygroma -- Second-trimester sonographic screening -- Second-trimester serum screening -- Combined first- and second-trimester screening -- Screening in multiple gestations -- Screening for neural tube defects -- Cell-free fetal DNA (cffDNA) screening for fetal aneuploidy -- Scientific basis of cffDNA screening -- Limitations of cffDNA screening -- CffDNA screening performance -- Implementation of cffDNA testing in clinical practice -- References -- Part 3 Fetal Assessment -- Chapter 8 Sonographic Dating and Standard Fetal Biometry -- Pregnancy dating -- First trimester -- Second and third trimesters -- Estimation of fetal weight -- Macrosomia -- Fetal growth restriction -- Definition -- Symmetric versus asymmetric -- Timing of diagnosis -- Risk factors -- Outcome -- Management -- Fetal arterial Doppler -- Venous Doppler and fetal growth restriction -- Clinical application -- References -- Chapter 9 Antepartum Fetal Monitoring -- Nonstress test -- Biophysical profile -- Modified biophysical profile (NST/amniotic fluid volume) -- Doppler velocimetry -- References. Chapter 10 Interpreting Intrapartum Fetal Heart Tracings -- Components of EFM documentation -- Baseline FHR -- Baseline FHR variability -- Accelerations -- Decelerations -- Uterine contractions -- Changes and trends in FHR over time -- Interpretation of EFM -- Category I -- Category III -- Category II -- Management of FHR abnormalities in labor -- Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) -- Tachysystole with fetal heart rate changes -- Maternal hypotension -- Maternal repositioning -- Intravenous fluid bolus -- Maternal hyperoxygenation -- Amnioinfusion -- Fetal stimulation -- Future directions -- References -- Part 4 Maternal Disease -- Chapter 11 Sickle Cell Anemia -- Hemoglobin SCD -- Hemoglobin S/-thalassemia disease -- Management during pregnancy -- Acute pain -- Chronic pain -- Prophylactic red blood cell transfusions -- Other treatments -- Fetal assessment -- Labor and delivery -- Genetic evaluation -- CASE PRESENTATION -- References -- Chapter 12 Anemia -- Consequences -- Causes of anemia in pregnancy -- Diagnostic workup and treatment -- Macrocytic anemia -- Normocytic anemia -- Microcytic anemia -- Iron supplementation in pregnancy -- Treatment of iron deficiency anemia -- References -- Chapter 13 Thrombocytopenia -- Maternal thrombocytopenia -- Gestational thrombocytopenia -- Autoimmune thrombocytopenia -- HELLP -- Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome -- Other causes -- Fetal thrombocytopenia -- Autoimmune thrombocytopenia -- Alloimmune thrombocytopenia -- References -- Chapter 14 Inherited and Acquired Thrombophilias -- Overview of hemostasis changes during pregnancy -- Inherited thrombophilias -- Factor V Leiden -- Prothrombin gene mutation (G2021A) -- Protein C deficiency -- Protein S deficiency -- Antithrombin deficiency -- Acquired thrombophilia. Antiphospholipid antibody syndrome -- Management considerations in patients with inherited or acquired thrombophilia -- Inherited thrombophilia -- Antiphospholipid antibody syndrome -- Summary -- References -- Chapter 15 Thromboembolic Disorders -- Physiology of hemostasis -- Platelet plug formation -- The coagulation cascade -- Endogenous anticoagulants -- Pathophysiology of and risk factors for thrombosis in pregnancy -- Diagnosis of venous thromboembolism -- Deep venous thrombosis -- Pulmonary embolus -- Conclusion -- References -- Chapter 16 Cardiac Disease in Pregnancy -- Risk assessment and risk-appropriate care -- Antenatal care and optimization -- First trimester -- Second trimester -- Third trimester -- Multidisciplinary delivery planning -- Mode of delivery -- Analgesia and anesthesia -- Monitoring and emergency preparedness -- Postpartum and interconception care -- Conclusion -- References -- Chapter 17 Renal Disease -- Physiological changes in renal function during pregnancy -- Anatomic changes in the urinary tract during pregnancy -- Renal disease in pregnancy -- Proteinuria -- Chronic kidney disease -- Mild renal insufficiency -- Moderate and severe renal insufficiency -- Hypertensive disorders with renal insufficiency -- Renal dialysis -- Renal transplantation -- Management of pregnancies complicated by renal disease -- Conclusion -- References -- Chapter 18 Pregnancy in Transplant Patients -- Prepregnancy assessment and counseling -- Antepartum care -- Review of common agents for maintenance immunosuppression -- Kidney transplant -- Other organ transplant patients -- Kidney-pancreas -- Liver -- Heart -- Lung -- Other transplant groups -- Uterus -- Intrapartum management -- Obstetric emergencies -- The baby -- References -- Chapter 19 Gestational Diabetes Mellitus -- Risk factors for gestational diabetes. Therapeutic modalities in gestational diabetes -- Antenatal testing -- Delivery: when and how to deliver -- Postpartum considerations -- References -- Chapter 20 Diabetes Mellitus -- Initial evaluation -- Regulating maternal glycemia -- Management during pregnancy -- Management of insulin during labor -- References -- Chapter 21 Thyroid Disorders -- Diagnosis -- Additional studies -- Hypothyroidism -- Implications for pregnancy -- Treatment -- Hyperthyroidism -- Implications for pregnancy -- Management -- Thyroid storm management [3,4,10] -- References -- Chapter 22 Asthma -- Definition of asthma -- Effect of pregnancy on the course of asthma -- Clinical observations -- Mechanisms -- Effect of asthma on pregnancy -- Clinical observations -- Mechanisms -- Diagnosis of asthma during pregnancy -- Management -- Assessment and monitoring -- Control of factors contributing to severity -- Patient education -- Pharmacologic therapy -- Chronic asthma -- Acute asthma -- Management during labor and delivery -- Conclusion -- References -- Chapter 23 Epilepsy -- Contraception -- Fertility -- Preconception counseling -- Folic acid -- Seizures during pregnancy -- ASM risks: Structural and neurodevelopmental teratogenicity -- Management during pregnancy -- Prenatal screening -- ASM levels -- Peripartum care -- Labor and delivery -- Maternal outcomes -- Postpartum care -- ASM management and seizure risk -- Breastfeeding -- Postpartum depression -- Summary -- References -- Chapter 24 Chronic Hypertension -- Definition -- Diagnosis -- Preconceptional counseling -- Morbidity and mortality -- Diagnosis and evaluation in pregnancy -- Treatment during pregnancy -- Antepartum fetal assessment -- Delivery -- Postpartum care -- References -- Chapter 25 Systemic Lupus Erythematosus -- Epidemiology -- Etiology -- Pathogenesis -- Differential diagnosis -- Morbidity. General morbidity and mortality. |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-9910830543503321 |
| Hoboken, NJ : , : Wiley-Blackwell, , 2024 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong
| Queenan's management of high-risk pregnancy : an evidence-based approach / / edited by Charles J. Lockwood, Catherine Y. Spong |
| Edizione | [7th ed.] |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley-Blackwell, , 2024 |
| Descrizione fisica | 1 online resource (502 pages) |
| Disciplina | 618.3 |
| Soggetto topico |
Pregnancy Complications
Pregnancy, High-Risk Evidence-Based Medicine - methods |
| ISBN |
1-119-63654-X
1-119-63653-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Foreword -- Preface -- Acknowledgments -- Part 1 Factors of High-Risk Pregnancy -- Chapter 1 Overview of High-Risk Pregnancy -- Chapter 2 Nutrition in Pregnancy -- Fetal growth -- Body mass index, weight gain, and adverse pregnancy outcomes -- Obesity -- Nutrition assessment and counseling -- Food security -- Energy intake during pregnancy -- Healthy dietary pattern in pregnancy -- Multivitamins -- Micronutrients in pregnancy -- Iron -- Folate/folic acid -- Calcium -- Vitamin D -- Iodine -- Vitamin toxicity -- Caffeine consumption in pregnancy -- Seafood consumption in pregnancy -- Multifetal pregnancy -- Nutrition during lactation -- Conclusion -- References -- Chapter 3 Alcohol and Substance Use Disorder -- Introduction -- Screening and testing for substance use disorder -- Alcohol -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Opioids -- Maternal effects -- Effects on the fetus -- Prenatal treatment -- Intrapartum and postpartum care -- Cannabis -- Stimulants -- Vaping (E-cigarettes) -- Benzodiazepines -- References -- Chapter 4 Environmental Agents and Reproductive Risk -- Background incidence of adverse outcome -- Biologic evidence of toxicity -- General principles -- Specific agents -- Lead -- Mercury -- Pesticides and herbicides -- Polychlorinated biphenyls -- Polybrominated diphenyl ethers -- Organic solvents -- Perfluorochemicals -- Video display terminals -- Bisphenol A -- Phthalates -- Air pollutants -- References -- Part 2 Genetics -- Chapter 5 Genetic Screening for Mendelian Disorders -- Family history -- Mendelian inheritance -- Carrier screening -- Carrier screening guidelines -- Hemoglobinopathies -- Cystic fibrosis -- Spinal muscular atrophy -- Fragile X syndrome -- Jewish genetic diseases -- Prenatal diagnosis -- Newborn screening.
References -- Chapter 6 Screening for Congenital Heart Disease -- Introduction -- Screening low-risk populations -- Benefits of cardiac screening -- High-risk populations for fetal echocardiography -- Normal fetal heart anatomy -- Technique -- Two-dimensional cross-sectional imaging -- Four-chamber view -- Ventricular outflow tracts -- Three-vessel and three-vessel trachea views -- Additional cardiac views -- Color Doppler imaging -- Expectations from cardiac screening -- Four-chamber view -- Addition of outflow tract views and three-vessel views -- Conclusion -- References -- Chapter 7 First- and Second-Trimester Screening for Fetal Aneuploidy and Neural Tube Defects -- First-trimester sonographic screening -- Combined first-trimester serum and sonographic screening -- First-trimester cystic hygroma -- Second-trimester sonographic screening -- Second-trimester serum screening -- Combined first- and second-trimester screening -- Screening in multiple gestations -- Screening for neural tube defects -- Cell-free fetal DNA (cffDNA) screening for fetal aneuploidy -- Scientific basis of cffDNA screening -- Limitations of cffDNA screening -- CffDNA screening performance -- Implementation of cffDNA testing in clinical practice -- References -- Part 3 Fetal Assessment -- Chapter 8 Sonographic Dating and Standard Fetal Biometry -- Pregnancy dating -- First trimester -- Second and third trimesters -- Estimation of fetal weight -- Macrosomia -- Fetal growth restriction -- Definition -- Symmetric versus asymmetric -- Timing of diagnosis -- Risk factors -- Outcome -- Management -- Fetal arterial Doppler -- Venous Doppler and fetal growth restriction -- Clinical application -- References -- Chapter 9 Antepartum Fetal Monitoring -- Nonstress test -- Biophysical profile -- Modified biophysical profile (NST/amniotic fluid volume) -- Doppler velocimetry -- References. Chapter 10 Interpreting Intrapartum Fetal Heart Tracings -- Components of EFM documentation -- Baseline FHR -- Baseline FHR variability -- Accelerations -- Decelerations -- Uterine contractions -- Changes and trends in FHR over time -- Interpretation of EFM -- Category I -- Category III -- Category II -- Management of FHR abnormalities in labor -- Placement of internal monitors (intrauterine pressure catheter, fetal scalp electrode) -- Tachysystole with fetal heart rate changes -- Maternal hypotension -- Maternal repositioning -- Intravenous fluid bolus -- Maternal hyperoxygenation -- Amnioinfusion -- Fetal stimulation -- Future directions -- References -- Part 4 Maternal Disease -- Chapter 11 Sickle Cell Anemia -- Hemoglobin SCD -- Hemoglobin S/-thalassemia disease -- Management during pregnancy -- Acute pain -- Chronic pain -- Prophylactic red blood cell transfusions -- Other treatments -- Fetal assessment -- Labor and delivery -- Genetic evaluation -- CASE PRESENTATION -- References -- Chapter 12 Anemia -- Consequences -- Causes of anemia in pregnancy -- Diagnostic workup and treatment -- Macrocytic anemia -- Normocytic anemia -- Microcytic anemia -- Iron supplementation in pregnancy -- Treatment of iron deficiency anemia -- References -- Chapter 13 Thrombocytopenia -- Maternal thrombocytopenia -- Gestational thrombocytopenia -- Autoimmune thrombocytopenia -- HELLP -- Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome -- Other causes -- Fetal thrombocytopenia -- Autoimmune thrombocytopenia -- Alloimmune thrombocytopenia -- References -- Chapter 14 Inherited and Acquired Thrombophilias -- Overview of hemostasis changes during pregnancy -- Inherited thrombophilias -- Factor V Leiden -- Prothrombin gene mutation (G2021A) -- Protein C deficiency -- Protein S deficiency -- Antithrombin deficiency -- Acquired thrombophilia. Antiphospholipid antibody syndrome -- Management considerations in patients with inherited or acquired thrombophilia -- Inherited thrombophilia -- Antiphospholipid antibody syndrome -- Summary -- References -- Chapter 15 Thromboembolic Disorders -- Physiology of hemostasis -- Platelet plug formation -- The coagulation cascade -- Endogenous anticoagulants -- Pathophysiology of and risk factors for thrombosis in pregnancy -- Diagnosis of venous thromboembolism -- Deep venous thrombosis -- Pulmonary embolus -- Conclusion -- References -- Chapter 16 Cardiac Disease in Pregnancy -- Risk assessment and risk-appropriate care -- Antenatal care and optimization -- First trimester -- Second trimester -- Third trimester -- Multidisciplinary delivery planning -- Mode of delivery -- Analgesia and anesthesia -- Monitoring and emergency preparedness -- Postpartum and interconception care -- Conclusion -- References -- Chapter 17 Renal Disease -- Physiological changes in renal function during pregnancy -- Anatomic changes in the urinary tract during pregnancy -- Renal disease in pregnancy -- Proteinuria -- Chronic kidney disease -- Mild renal insufficiency -- Moderate and severe renal insufficiency -- Hypertensive disorders with renal insufficiency -- Renal dialysis -- Renal transplantation -- Management of pregnancies complicated by renal disease -- Conclusion -- References -- Chapter 18 Pregnancy in Transplant Patients -- Prepregnancy assessment and counseling -- Antepartum care -- Review of common agents for maintenance immunosuppression -- Kidney transplant -- Other organ transplant patients -- Kidney-pancreas -- Liver -- Heart -- Lung -- Other transplant groups -- Uterus -- Intrapartum management -- Obstetric emergencies -- The baby -- References -- Chapter 19 Gestational Diabetes Mellitus -- Risk factors for gestational diabetes. Therapeutic modalities in gestational diabetes -- Antenatal testing -- Delivery: when and how to deliver -- Postpartum considerations -- References -- Chapter 20 Diabetes Mellitus -- Initial evaluation -- Regulating maternal glycemia -- Management during pregnancy -- Management of insulin during labor -- References -- Chapter 21 Thyroid Disorders -- Diagnosis -- Additional studies -- Hypothyroidism -- Implications for pregnancy -- Treatment -- Hyperthyroidism -- Implications for pregnancy -- Management -- Thyroid storm management [3,4,10] -- References -- Chapter 22 Asthma -- Definition of asthma -- Effect of pregnancy on the course of asthma -- Clinical observations -- Mechanisms -- Effect of asthma on pregnancy -- Clinical observations -- Mechanisms -- Diagnosis of asthma during pregnancy -- Management -- Assessment and monitoring -- Control of factors contributing to severity -- Patient education -- Pharmacologic therapy -- Chronic asthma -- Acute asthma -- Management during labor and delivery -- Conclusion -- References -- Chapter 23 Epilepsy -- Contraception -- Fertility -- Preconception counseling -- Folic acid -- Seizures during pregnancy -- ASM risks: Structural and neurodevelopmental teratogenicity -- Management during pregnancy -- Prenatal screening -- ASM levels -- Peripartum care -- Labor and delivery -- Maternal outcomes -- Postpartum care -- ASM management and seizure risk -- Breastfeeding -- Postpartum depression -- Summary -- References -- Chapter 24 Chronic Hypertension -- Definition -- Diagnosis -- Preconceptional counseling -- Morbidity and mortality -- Diagnosis and evaluation in pregnancy -- Treatment during pregnancy -- Antepartum fetal assessment -- Delivery -- Postpartum care -- References -- Chapter 25 Systemic Lupus Erythematosus -- Epidemiology -- Etiology -- Pathogenesis -- Differential diagnosis -- Morbidity. General morbidity and mortality. |
| Altri titoli varianti | Management of high-risk pregnancy |
| Record Nr. | UNINA-9910841064203321 |
| Hoboken, NJ : , : Wiley-Blackwell, , 2024 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes
| Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes |
| Pubbl/distr/stampa | [Place of publication not identified], : Agency for Healthcare Research and Quality, 2008 |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.4/62 |
| Collana | Evidence report/technology assessment Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes |
| Soggetto topico |
Diabetes - Treatment
Risk Investigative Techniques Diabetes Mellitus Diagnostic Techniques and Procedures Risk Management Pregnancy Complications Pregnancy Epidemiologic Measurements Endocrine System Diseases Probability Organization and Administration Public Health Female Urogenital Diseases and Pregnancy Complications Reproduction Glucose Metabolism Disorders Statistics as Topic Metabolic Diseases Disease Environment and Public Health Health Services Administration Reproductive Physiological Phenomena Epidemiologic Methods Delivery of Health Care Health Care Evaluation Mechanisms Nutritional and Metabolic Diseases Reproductive and Urinary Physiological Phenomena Quality of Health Care Health Care Quality, Access, and Evaluation Diabetes, Gestational Risk Assessment Pregnancy, High-Risk Methods Diabetes Complications Diagnosis Health & Biological Sciences Communicable Diseases |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910698326703321 |
| [Place of publication not identified], : Agency for Healthcare Research and Quality, 2008 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||